Acutaas Chemicals reports strong Q2 FY26 growth, strategic expansion

Acutaas Chemicals Limited announced its Q2 FY26 financial results, with revenue from operations growing 24.1% year-on-year to ₹3,062 million. This growth was primarily driven by strong performance in Advanced Pharmaceutical Intermediates and stable contributions from Specialty Chemicals. The company's EBITDA for Q2 FY26 surged by 94.8% to ₹953 million, expanding the EBITDA margin to 31.1% from 19.8% in Q2 FY25. Net profit after tax (PAT) also saw a substantial increase of 91.3% to ₹719 million.

The board of directors approved the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025. The company’s focus on building a sustainable business foundation and expanding into new growth verticals like Battery Chemicals and Semiconductors contributed to this strong performance.

In line with strategic expansion, Acutaas Advance Material Limited (AAML), a wholly-owned subsidiary, entered a joint venture with J & Materials Co. Ltd., a South Korean company, holding 75% of the share capital in Indichem Inc. AAML also made an investment of ₹44.68 crores in Indichem Inc. through equity share subscription during the quarter. Furthermore, two wholly-owned subsidiary companies, Baba Advance Materials Limited and Ami Organics Electrolytes Private Limited, were renamed Acutaas Advance Material Limited and Acutaas Chemicals Electrolytes Private Limited, respectively, in July 2025.